The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study protocol of an open-label, single-arm, phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC).
 
Linde Kehmann
Employment - SERVIER
 
Marie Berres
No Relationships to Disclose
 
Maria A Gonzalez-Carmona
No Relationships to Disclose
 
Dominik Paul Modest
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Sanofi; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Cor2Ed; Incyte; IQvia; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Roche; SERVIER
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Raphael Mohr
No Relationships to Disclose
 
Alexander Wree
No Relationships to Disclose
 
Marino Venerito
No Relationships to Disclose
 
Christian Strassburg
No Relationships to Disclose
 
Verena Keitel
No Relationships to Disclose
 
Christian Trautwein
No Relationships to Disclose
 
Tom Luedde
No Relationships to Disclose
 
Christoph Roderburg
Honoraria - Eickeler
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; MSD; Roche; SERVIER
Research Funding - Bracco Diagnostics; SERVIER